Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Chinese partner
View:
Post by Bucknelly21 on Feb 03, 2022 12:26pm

Chinese partner

Looking at linkden this morning, Paul looks to be connected to a company called beigene, could this be a possible partner?
Comment by palinc2000 on Feb 03, 2022 12:35pm
Comment by palinc2000 on Feb 03, 2022 12:35pm
Comment by palinc2000 on Feb 03, 2022 12:37pm
Stockhouse wontt let me reply in Chinese
Comment by longterm56 on Feb 03, 2022 12:51pm
"beigene" ?  clever name, I wonder if they are located in Beijing???    -LT
Comment by SPCEO1 on Feb 03, 2022 12:52pm
Nice find! BGNE is a cancer focused company listed on NASDAQ, headquartered in Beijing and has a $25 billion market cap.It has $3.9 bilion in cash but is burning through that reasonably quickly ($888 million cash burn in the last twelve months). Its stock is covered by 17 brokers including virtually all the top tier brokers. BGNE would be able to easily sign a partnership deal for a meaningful ...more  
Comment by SPCEO1 on Feb 03, 2022 12:56pm
JP Morgan picked up coverae on 1/12/22 - here is the first page from their report: We initiate coverage on the A-share of BeiGene (BGNE) with a DCF-derived PT of Rmb238 and OW rating. Concurrently, we assume coverage of the H-share and ADR of the company both at OW with respective PTs of HK$222 and US$370. BeiGene is a commercial-stage biopharmaceutical company with proven capabilities ...more  
Comment by Bucknelly21 on Feb 03, 2022 2:53pm
I almost felt like this was to coincidental to not have meaning 
Comment by qwerty22 on Feb 03, 2022 1:03pm
I think Beigene are seen by some as the most likely to become a global Pharma company. Something from China to eventually compete with the Pfizers of this world. Many seem to see them as the most legitimate of the up-and-coming Chinese biotech. It would be about as good as it could be to have them onboard. I'm going to say I'll remain sceptical until something materializes. It's likely ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities